Posts

• Employee Spotlight: Audrey Muck (July 26, 2024)
• Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 (July 2, 2024)
• Employee Spotlight: Dexter Whack (June 28, 2024)
• Latest STRIKE-PE Data Published in JVIR Showing that Penumbra’s Computer Assisted Vacuum Thrombectomy Technology For Pulmonary Embolism Improved Patient Outcomes (June 25, 2024)
• 101-Year-Old Stroke Survivor Shares Story in Hopes of Helping Others (June 24, 2024)
• Penumbra Announces European Launch of its Most Advanced Neuro Access Offerings: BMX81 and BMX96 (June 17, 2024)
• Penumbra, Inc. to Present at the Truist Securities MedTech Conference (June 4, 2024)
• Penumbra, Inc. to Present at the William Blair Growth Stock Conference (May 23, 2024)
• Employee Spotlight: Mitchel Kinghorn (May 23, 2024)
• Penumbra, Inc. Reports First Quarter 2024 Financial Results (May 7, 2024)
• Penumbra Launches Latest Innovations in Neuro Embolization Intervention: MIDWAY™ Intermediate Catheters (May 7, 2024)
• Penumbra Expands Stroke Portfolio in Europe (May 7, 2024)
• Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference (May 1, 2024)
• This Survive Stroke Week – Know the Important Signs and Symptoms to Survive and Thrive (April 30, 2024)
• Employee Spotlight: Jacquel Prazych (April 23, 2024)
• Penumbra Launches Lightning Flash 2.0 – Latest CAVT Technology Designed to Rapidly Remove Blood Clots (April 23, 2024)
• Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 (April 9, 2024)
• Employee Spotlight: Jeremiah Christie (March 28, 2024)
• New Data Show Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Used in a Single-Session Without Overnight Thrombolytics Is Safe and Effective for Patients with LE-ALI (March 27, 2024)
• Launch of EMBOLIZE Clinical Trial Is First-of-its-kind Study to Explore Treatment for Pelvic Venous Disorders (March 25, 2024)
• Employee Spotlight: Meenakshi Mattu (February 29, 2024)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (February 22, 2024)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024 (February 1, 2024)
• New STRIDE Data on Aspiration Thrombectomy Show No Sex Differences in Target Limb Salvage Rates in Lower Extremity ALI Patients (January 29, 2024)
• Employee Spotlight: Rafael Fideles (January 22, 2024)
• Penumbra Launches Indigo^™ System CAT^™ RX Catheter in Europe to Address Acute Coronary Syndrome (January 12, 2024)
• Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference (December 19, 2023)
• Employee Spotlight: Phillip Smith Jr. (December 18, 2023)
• Employee Spotlight: Kale Cordero (November 28, 2023)
• First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy – Lightning Flash™ – for Treatment of Acute Pulmonary Embolism (November 28, 2023)
• Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference (November 14, 2023)
• Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans (November 10, 2023)
• Penumbra, Inc. Reports Third Quarter 2023 Financial Results (November 2, 2023)
• New Late Breaking Data Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy Technology For Pulmonary Embolism Improved Patient Outcomes (November 1, 2023)
• Celebrating National Physical Therapy Month (October 26, 2023)
• Employee Spotlight: Mars Jokela (October 24, 2023)
• 2023 World Thrombosis Day (October 12, 2023)
• Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023 (October 5, 2023)
• Employee Spotlight: Meet Jacob Zepeda (September 19, 2023)
• Penumbra, Inc. to Present at Upcoming Investor Conferences (August 23, 2023)
• Employee Spotlight: Meet Andrea Hoffman (August 22, 2023)
• Penumbra, Inc. Reports Second Quarter 2023 Financial Results (August 1, 2023)
• Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference (July 26, 2023)
• Employee Spotlight: Meet Gyan Bhatia (July 19, 2023)
• Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023 (July 5, 2023)
• Employee Spotlight: Meet Shyam Kuppurathanam (June 15, 2023)
• Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration (June 1, 2023)
• Employee Spotlight: Meet Jemy Allen (May 31, 2023)
• Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference (May 24, 2023)
• New Data Demonstrates Indigo Aspiration System Improves ALI Patient Outcomes – STRIDE Study (May 3, 2023)
• Penumbra, Inc. Reports First Quarter 2023 Financial Results (May 2, 2023)
• Employee Spotlight: Meet Megan Loy (April 6, 2023)
• Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023 (April 4, 2023)
• Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality (April 4, 2023)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (February 23, 2023)
• Employee Spotlight: Meet Nancy Thao (February 22, 2023)
• Penumbra, Inc. to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference (February 16, 2023)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023 (January 26, 2023)
• Employee Spotlight: Meet Daniel Escobar (January 13, 2023)
• Penumbra Launches Latest Innovation in Mechanical Thrombectomy: Lightning Flash^™ (January 10, 2023)
• Penumbra, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference (December 19, 2022)
• Employee Spotlight: Meet Gigi San Juan (November 18, 2022)
• Penumbra Launches First Hands-Free, Full Body Virtual Reality-Based Offering for Rehabilitation, Expanding REAL^® System Platform (November 15, 2022)
• Penumbra, Inc. Reports Third Quarter 2022 Financial Results (November 3, 2022)
• Penumbra, Inc. to Present at the Jefferies London Healthcare Conference (November 1, 2022)
• Employee Spotlight: Meet Greg J. Hakanson (October 12, 2022)
• Penumbra, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 3, 2022 (October 6, 2022)
• Penumbra and Asahi Intecc Partner With Goal of Introducing Indigo™ System Including Lightning™ Intelligent Aspiration to Japan (September 22, 2022)
• Penumbra Announces European Launch of RED® Reperfusion Catheters for Stroke Care (September 7, 2022)
• Latest Data Demonstrates Penumbra System and RED® Reperfusion Catheters Effective for Broad Stroke Care (August 25, 2022)
• Why Representation Matters: <p>Q&A with Dr. Elizabeth Genovese (August 19, 2022)
• Penumbra, Inc. Reports Second Quarter 2022 Financial Results (August 4, 2022)
• Penumbra, Inc. to Present at the Canaccord Genuity 42nd Annual Growth Conference (July 27, 2022)
• Penumbra, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022 (July 7, 2022)
• Employee Spotlight: Meet Durga Devi (June 14, 2022)
• Penumbra, Inc. Reports First Quarter 2022 Financial Results (May 3, 2022)
• Penumbra, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference (April 26, 2022)
• Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration (April 14, 2022)
• Penumbra, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 3, 2022 (April 5, 2022)
• National Doctors Day (March 30, 2022)
• Penumbra, Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference (March 28, 2022)
• Employee Spotlight: Meet Norem Soriano (March 14, 2022)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results (February 22, 2022)
• Penumbra, Inc. to Present at Citi's 2022 Virtual Healthcare Conference (February 10, 2022)
• Employee Spotlight: Meet Faye Titchenal (February 1, 2022)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 22, 2022 (February 1, 2022)
• Health: January Is National Blood Donor Month (January 26, 2022)
• Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference (December 22, 2021)
• New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra's Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome (November 5, 2021)
• Penumbra, Inc. Reports Third Quarter 2021 Financial Results (November 3, 2021)
• Penumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 (October 6, 2021)
• Penumbra Acquires Sixense Enterprises (October 4, 2021)
• Penumbra, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference (August 31, 2021)
• Penumbra, Inc. to Present at the 2021 Wells Fargo Virtual Healthcare Conference (August 26, 2021)
• Penumbra Introduces REAL® i-Series™, Expanding REAL Immersive System to Support Broad Range of Care Providers and Mental Health Professionals (August 10, 2021)
• Penumbra, Inc. Reports Second Quarter 2021 Financial Results (August 9, 2021)
• Penumbra, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference (July 28, 2021)
• Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021 (July 12, 2021)
• Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients (June 23, 2021)
• Penumbra, Inc. to Present at the William Blair 41st Annual Growth Stock Virtual Conference (May 18, 2021)
• Penumbra, Inc. Reports First Quarter 2021 Financial Results (May 4, 2021)
• Penumbra, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference (April 27, 2021)
• Penumbra, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 4, 2021 (April 13, 2021)
• Penumbra Announces U.S. Commercial Availability of INDIGO System Lightning 7 (March 18, 2021)
• Meetings & Events: Penumbra Announces Participation at IVRHA's Annual Symposium (February 26, 2021)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results (February 23, 2021)
• Penumbra, Inc. to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference (February 10, 2021)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 23, 2021 (February 2, 2021)
• Penumbra Affirms Original Clinical Research Authored by Co-Founder and Chief Innovator Dr. Arani Bose (January 12, 2021)
• Penumbra Announces Preliminary Unaudited Revenue for the Fourth Quarter and Full Year 2020 (January 11, 2021)
• Penumbra Announces Penumbra JET 7 Reperfusion Catheter with Xtra Flex Technology Voluntary Recall (December 15, 2020)
• Penumbra Responds to False Allegations from Short Sellers Seeking to Manipulate Company Stock and Remove Life-saving Medical Devices from the Market (December 8, 2020)
• Penumbra, Inc. to Participate in CEO Discussion with Bank of America (December 4, 2020)
• Penumbra's Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism (November 20, 2020)
• Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism (November 10, 2020)
• Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum (November 6, 2020)
• Penumbra, Inc. Reports Third Quarter 2020 Financial Results (October 28, 2020)
• Penumbra, Inc. Schedules Third Quarter 2020 Earnings Release and Conference Call for October 28, 2020 (September 29, 2020)
• Penumbra, Inc. to Present at the Morgan Stanley 18th Annual Global Healthcare Conference (September 3, 2020)
• Penumbra, Inc. to Present at the Wells Fargo 2020 Virtual Healthcare Conference (August 26, 2020)
• Penumbra, Inc. Reports Second Quarter 2020 Financial Results (August 3, 2020)
• Penumbra, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference (July 29, 2020)
• Penumbra, Inc. Schedules Second Quarter 2020 Earnings Release and Conference Call for August 3, 2020 (July 20, 2020)
• Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership (July 14, 2020)
• Penumbra, Inc. to Present at the William Blair 40th Annual Growth Stock Conference (May 29, 2020)
• Penumbra, Inc. Announces Pricing of Offering of Common Stock (May 27, 2020)
• Penumbra, Inc. Announces Launch of Offering of $100,000,000 of Shares of its Common Stock (May 27, 2020)
• Penumbra, Inc. Announces Virtual 2020 Annual Meeting of Stockholders (May 15, 2020)
• Penumbra Announces Management Transition (May 12, 2020)
• Penumbra, Inc. Reports First Quarter 2020 Financial Results (May 7, 2020)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2020 Health Care Conference (April 29, 2020)
• Penumbra, Inc. Schedules First Quarter 2020 Earnings Release and Conference Call for May 7, 2020 (April 23, 2020)
• Penumbra Provides Update on COVID-19 Response and Impact (April 6, 2020)
• International Women's Day 2020 (March 12, 2020)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results (February 25, 2020)
• Employee Spotlight: Meet Joy Backensto (February 25, 2020)
• Health: February is American Heart Month (February 13, 2020)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for February 25, 2020 (February 11, 2020)
• Meetings & Events: REAL™ Immersive System Debuts at APTA's CSM 2020 (February 10, 2020)
• Employee Spotlight: Meet Jim Lancaster (January 21, 2020)
• Meetings & Events: Penumbra Announces Key Events at ISET 2020 (January 17, 2020)
• Penumbra Announces FDA Clearance of Indigo® Aspiration System for Treatment of Pulmonary Embolism (January 9, 2020)
• Penumbra, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference (December 31, 2019)
• Employee Spotlight: Meet Olaf Beyer (December 10, 2019)
• Maggie Yuen Appointed Chief Financial Officer Of Penumbra (November 25, 2019)
• Meetings & Events: Penumbra Announces Key Events at SVIN 2019 (November 19, 2019)
• Penumbra, Inc. Announces Investor Day 2019 (November 19, 2019)
• Meetings & Events: Penumbra Announces Key Events at VEITHsymposium® (November 15, 2019)
• Penumbra, Inc. Reports Third Quarter 2019 Financial Results (November 7, 2019)
• Penumbra Indigo® Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints (November 6, 2019)
• Employee Spotlight: Meet Phal Cindy Suon (November 5, 2019)
• Meetings & Events: Penumbra Announces Key Events at VIVA 2019 (November 2, 2019)
• Meetings & Events: Penumbra Announces Participation at CNS 2019 (October 26, 2019)
• Penumbra, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 7, 2019 (October 17, 2019)
• Health: Global Campaigns Highlight Thrombosis and Stroke Awareness (October 11, 2019)
• Penumbra Announces First Patient Enrolled in Study of Mechanical Power Aspiration for Thrombus Removal in Coronary Vessels (October 10, 2019)
• Employee Spotlight: Meet Brihony Gills (October 4, 2019)
• Meetings & Events: Penumbra Announces Participation at TCT 2019 (September 20, 2019)
• Sri Kosaraju Promoted to President and CFO of Penumbra (August 29, 2019)
• Penumbra, Inc. to Present at the Morgan Stanley 17th Annual Global Healthcare Conference (August 27, 2019)
• Penumbra, Inc. to Present at the 2019 Wells Fargo Healthcare Conference (August 21, 2019)
• Employee Spotlight: Meet Oliver Carpenter (August 19, 2019)
• Meetings & Events: Penumbra Announces Participation at AMP 2019 (August 12, 2019)
• Penumbra, Inc. Reports Second Quarter 2019 Financial Results (August 6, 2019)
• Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019 (July 22, 2019)
• Meetings & Events: Penumbra Announces Key Events at SNIS 2019 (July 18, 2019)
• Penumbra, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference (July 17, 2019)
• Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 (July 16, 2019)
• Penumbra, Inc. to Present at the BMO 2019 Prescriptions for Success Healthcare Conference (June 11, 2019)
• Employee Spotlight: Meet Danielle Chu (June 5, 2019)
• Penumbra, Inc. to Present at the Goldman Sachs 40th Annual Global Healthcare Conference (May 29, 2019)
• Meetings & Events: Penumbra Announces Participation at SCAI 2019 (May 17, 2019)
• Health: May Highlights Stroke Awareness, High Blood Pressure Education (May 10, 2019)
• Employee Spotlight: Meet Cheryl Binney (May 7, 2019)
• Penumbra, Inc. Reports First Quarter 2019 Financial Results (May 7, 2019)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2019 Health Care Conference (May 1, 2019)
• Penumbra, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 7, 2019 (April 17, 2019)
• Meetings & Events: Penumbra Announces Participation at AANS 2019 (April 11, 2019)
• Meetings & Events: Penumbra Announces Key Events at SIR 2019 (March 22, 2019)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results (February 26, 2019)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 26, 2019 (January 30, 2019)
• Penumbra, Inc. Appoints Janet Leeds and Surbhi Sarna to its Board of Directors (January 18, 2019)
• Penumbra, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference (December 20, 2018)
• Employee Spotlight: Meet Holly Sit (December 11, 2018)
• Penumbra, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference (November 29, 2018)
• Penumbra, Inc. Reports Third Quarter 2018 Financial Results (November 5, 2018)
• Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018 (October 15, 2018)
• Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health (September 4, 2018)
• Penumbra Launches Latest Advancements in Stroke Thrombectomy Aspiration Technology (September 4, 2018)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 22, 2018)
• Penumbra, Inc. Reports Second Quarter 2018 Financial Results (August 7, 2018)
• Penumbra, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference (July 19, 2018)
• Penumbra, Inc. Schedules Second Quarter 2018 Earnings Release and Conference Call for August 7, 2018 (July 17, 2018)
• Penumbra, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference (May 29, 2018)
• Penumbra, Inc. Reports First Quarter 2018 Financial Results (May 8, 2018)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2018 Health Care Conference (May 2, 2018)
• Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018 (April 18, 2018)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results (February 27, 2018)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern Time (January 30, 2018)
• Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke (January 25, 2018)
• Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke (January 25, 2018)
• Penumbra Announces Key Events at International Stroke Conference 2018 Meeting (January 17, 2018)
• Penumbra Announces the Formation of Joint Venture, MVI Health (January 4, 2018)
• Penumbra, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference (December 21, 2017)
• Penumbra, Inc. Reports Third Quarter 2017 Financial Results (November 7, 2017)
• Penumbra, Inc. Schedules Third Quarter 2017 Earnings Release and Conference Call for November 7, 2017 at 5:00 PM Eastern Time (October 24, 2017)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 24, 2017)
• Penumbra, Inc. Reports Second Quarter 2017 Financial Results (August 8, 2017)
• Penumbra, Inc. Schedules Second Quarter 2017 Earnings Release and Conference Call for August 8, 2017 at 4:30 PM Eastern Time (July 25, 2017)
• Penumbra, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference (July 25, 2017)
• Penumbra, Inc. Promotes Daniel Davis to Chief Commercial Officer (July 5, 2017)
• Penumbra, Inc. Reports First Quarter 2017 Financial Results (May 9, 2017)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference (May 3, 2017)
• Penumbra, Inc. Schedules First Quarter 2017 Earnings Release and Conference Call for May 9, 2017 at 4:30 PM Eastern Time (April 25, 2017)
• Penumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors (April 21, 2017)
• Penumbra, Inc. Announces Pricing of Offering of 1,300,000 Shares of its Common Stock (March 16, 2017)
• Penumbra, Inc. Announces Launch of Offering of 1,300,000 Shares of its Common Stock (March 15, 2017)
• Penumbra Announces Key Events at Society of Interventional Radiology 2017 Meeting (March 2, 2017)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results (February 28, 2017)
• Independent Study Supports Use of Penumbra Aspiration as Frontline Thrombectomy Therapy for Acute Ischemic Stroke (February 22, 2017)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for February 28, 2017 at 5:00 PM Eastern Time (February 14, 2017)
• Penumbra, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference (December 20, 2016)
• Penumbra, Inc. Appoints Thomas C. Wilder to its Board of Directors (December 19, 2016)
• Penumbra, Inc. Announces Resignation of Board Member (November 15, 2016)
• Penumbra to Highlight Peripheral Vascular Technologies at AIMsymposium and VEITHsymposium in New York (November 10, 2016)
• Penumbra, Inc. Reports Third Quarter 2016 Financial Results (November 3, 2016)
• Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum (October 27, 2016)
• Penumbra, Inc. Schedules Third Quarter 2016 Earnings Release and Conference Call for November 3, 2016 at 5:00 PM Eastern Time (October 20, 2016)
• Penumbra to Highlight Importance of Stroke Treatment at Upcoming Patient Awareness Events (September 27, 2016)
• Penumbra, Inc. Announces Participation at Upcoming Investor Conferences (August 18, 2016)
• Penumbra, Inc. Reports Second Quarter 2016 Financial Results (August 9, 2016)
• Randomized Penumbra 3D Trial of Next Generation Stent Retriever Meets Primary Endpoints (July 27, 2016)
• Penumbra Launches Newest Stroke Thrombectomy Technology ACE™68 Reperfusion Catheter at SNIS 2016 (July 25, 2016)
• Penumbra Announces Key Events at Society of NeuroInterventional Surgery 2016 Meeting (July 19, 2016)
• Penumbra, Inc. Schedules Second Quarter 2016 Earnings Release and Conference Call for August 9, 2016 at 4:30 PM Eastern Time (July 15, 2016)
• Penumbra, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference (July 15, 2016)
• Penumbra, Inc. Reports First Quarter 2016 Financial Results (May 9, 2016)
• Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference (April 27, 2016)
• Penumbra, Inc. Schedules First Quarter 2016 Earnings Release and Conference Call for May 9, 2016 at 4:30 PM Eastern Time (April 25, 2016)
• Penumbra to Launch LanternTM Microcatheter, Present Final Results of Multicenter Prism Trial on Indigo® System at SIR 2016 (March 31, 2016)
• Penumbra, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results (March 8, 2016)
• Penumbra, Inc. Appoints Kevin Sullivan to its Board of Directors (February 23, 2016)
• Penumbra, Inc. Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call for March 8, 2016 at 4:30 PM Eastern Time (February 23, 2016)
• Penumbra Introduces POD® Packing Coil for the Embolization of Peripheral Vessels and Aneurysms (January 6, 2016)
• Penumbra, Inc. to Present at the 34th Annual J.P. Morgan 2016 Healthcare Conference (December 28, 2015)
• Penumbra, Inc. Reports Third Quarter 2015 Financial Results (November 12, 2015)
• Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum (November 5, 2015)
• Penumbra, Inc. Schedules Third Quarter 2015 Earnings Release and Conference Call for November 12, 2015 at 4:30 PM Eastern Time (October 30, 2015)
• Penumbra, Inc. Announces Closing of its Initial Public Offering (September 23, 2015)
• Penumbra, Inc. Announces Pricing of Initial Public Offering (September 17, 2015)
• Study of Penumbra’s ACE64 Demonstrates High Revascularization Rates, Quick Procedure Times in Stroke Patients (July 28, 2015)
• Statement from Penumbra, Inc. Regarding American Heart Association/American Stroke Association Guidelines for the Early Management of Patients with Acute Ischemic Stroke (June 29, 2015)
• Penumbra ACE64 Cleared for Marketing by U.S. Food & Drug Administration for Acute Ischemic Stroke Patients (May 27, 2015)
• Sri Kosaraju Joins Penumbra, Inc., as Chief Financial Officer and Head of Strategy (March 3, 2015)
• Penumbra, Inc., to Launch POD™ Embolization Anchoring Device, Present Data on Peripheral Vascular Technologies at the Society of Interventional Radiology 2015 Meeting (February 27, 2015)
• Statement from Penumbra, Inc. Regarding Results of MR CLEAN and Other Studies of Intra-Arterial Treatments at the International Stroke Conference 2015 (February 11, 2015)
• Independent Study Demonstrates Stroke Patients Experience Superior Outcomes with Intra-Arterial Treatment vs. Tissue Plasminogen Activator (tPA) (December 17, 2014)
• Penumbra, Inc. Launches 5MAX™ ACE – The Newest Clot Extraction Device To Treat Acute Ischemic Stroke Patients (July 8, 2013)
• Penumbra, Inc. launches 5MAX™ DDC and 4MAX™ DDC Distal Delivery Catheters (February 4, 2013)
• Penumbra, Inc. Launches New 5MAX™ Reperfusion Catheter (August 22, 2012)
• Know where to go if stroke strikes: Penumbra, Inc. launches QuEST2StopStroke.com (July 17, 2012)
• Penumbra, Inc. Launches the New MAX™ System Reperfusion Catheters for Acute Ischemic Stroke Patients. (June 18, 2012)
• European launch of Penumbra Separator™ 3D announced at the Working Group in Interventional Neuroradiology (WIN) Seminar. (January 23, 2012)